# OnCo record folfox (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/folfox/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "folfox" ;
  schema:name "FOLFOX (5-FU, leucovorin, oxaliplatin)"@en ;
  schema:description "FOLFOX is the workhorse chemotherapy combination for bowel cancer, used after surgery to cure and in advanced disease as the backbone that targeted drugs are added to."@en ;
  schema:url <https://onco.cc/drugs/folfox/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/FOLFOX> ;
  owl:sameAs <http://www.wikidata.org/entity/Q117636> ;
  schema:citation <https://en.wikipedia.org/wiki/FOLFOX>, <https://doi.org/10.1200/JCO.2013.53.6995>, <https://doi.org/10.1200/JCO.2016.68.5776> ;
  onco:status "standard-of-care" ;
  onco:modality "Cytotoxic regimen" ;
  onco:approval "US 2004: Adjuvant stage III colon cancer (oxaliplatin, MOSAIC)" ;
  onco:related <https://onco.cc/drugs/folfiri/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/folfirinox/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/pancreatic-acinar-cell-carcinoma/>, <https://onco.cc/cancers/appendiceal-adenocarcinoma/>, <https://onco.cc/cancers/goblet-cell-adenocarcinoma/>, <https://onco.cc/cancers/localised-small-bowel-adenocarcinoma/>, <https://onco.cc/cancers/advanced-small-bowel-adenocarcinoma/>, <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/metastatic-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:trials <https://onco.cc/trials/breakwater/>, <https://onco.cc/trials/paradigm/>, <https://onco.cc/trials/atomic/>, <https://onco.cc/trials/mountaineer/>, <https://onco.cc/trials/nct07221357/>, <https://onco.cc/trials/nct07702032/>, <https://onco.cc/trials/nct05482893/>, <https://onco.cc/trials/nct07659795/>, <https://onco.cc/trials/nct04068610/>, <https://onco.cc/trials/nct03526835/>, <https://onco.cc/trials/nct06324357/>, <https://onco.cc/trials/nct02671435/>, <https://onco.cc/trials/nct07498725/>, <https://onco.cc/trials/abc-06/>, <https://onco.cc/trials/sevilla/>, <https://onco.cc/trials/combomatch-binimetinib-folfox/>, <https://onco.cc/trials/conko-003/>, <https://onco.cc/trials/sequoia/>, <https://onco.cc/trials/alliance-a021501/>, <https://onco.cc/trials/primus-001/>, <https://onco.cc/trials/mosaic/>, <https://onco.cc/trials/idea-collaboration/>, <https://onco.cc/trials/scot/>, <https://onco.cc/trials/foxtrot/>, <https://onco.cc/trials/eortc-40983/>, <https://onco.cc/trials/prospect/> .